Medications such as Ozempic and Saxenda have grown in popularity due to their ability to treat type 2 diabetes and assist in ...

Hope may be on the horizon, however, according to a new pilot study published on June 17 in Headache: The Journal of Head and Face Pain. This discovery may lead to a novel treatment approach that ...

Doctors explain why headaches are popular among Wegovy and Ozempic patients and how to treat and prevent them, including ...

Ozempic-like drugs used to treat type 2 diabetes and obesity may also treat migraine, ... If confirmed, however, the findings could open up a new line of inquiry for migraine treatment, ...

In a small trial of 31 people with chronic migraines who didn’t respond to other treatments, liraglutide slashed the number of days they experienced migraines by over half. Although the volunteers ...

Researchers say GLP-1 medicines might be able to help with migraines.

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this widespread impact, many sufferers find current preventive treatments ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life improvements occurring despite minimal weight changes.

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study showing the GLP-1 receptor agonist provided significant relief to sufferers ...

Type 2 diabetes patients on GLP-1 treatments, including Ozempic, have a lower risk of 10 types of obesity-related cancers compared to those on insulin, according to a new study.

How Ozempic Is Changing Diabetes Treatment Millions of patients rely on insulin. But with new drugs, some have been able to lower their doses or stop taking it altogether.